CMPX logo

CMPX
Compass Therapeutics Inc

734
Mkt Cap
$1B
Volume
3.7M
52W High
$6.88
52W Low
$1.33
PE Ratio
-12.35
CMPX Fundamentals
Price
$5.65
Prev Close
$5.78
Open
$5.73
50D MA
$5.81
Beta
1.55
Avg. Volume
2.62M
EPS (Annual)
-$0.3594
P/B
4.79
Rev/Employee
$24,285.71
$79.12
Loading...
Loading...
News
all
press releases
Monashee Investment Management LLC Has $4.38 Million Stake in Compass Therapeutics, Inc. $CMPX
Monashee Investment Management LLC grew its position in Compass Therapeutics, Inc. (NASDAQ:CMPX - Free Report) by 657.6% in the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·10h ago
News Placeholder
More News
News Placeholder
Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of "Moderate Buy" by Analysts
Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fourteen ratings firms that are currently covering the...
MarketBeat·9d ago
News Placeholder
Compass Therapeutics (CMPX) to Release Quarterly Earnings on Thursday
Compass Therapeutics (NASDAQ:CMPX) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...
MarketBeat·11d ago
News Placeholder
Is Compass Therapeutics, Inc. (CMPX) Outperforming Other Medical Stocks This Year?
Here is how Compass Therapeutics, Inc. (CMPX) and Ekso Bionics (EKSO) have performed compared to their sector so far this year.
Zacks·12d ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Raised to "Hold" at Wall Street Zen
Wall Street Zen upgraded shares of Compass Therapeutics from a "sell" rating to a "hold" rating in a research note on Monday...
MarketBeat·14d ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Craig Hallum
Craig Hallum began coverage on shares of Compass Therapeutics in a report on Friday. They set a "buy" rating and a $15.00 target price for the company...
MarketBeat·16d ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Cut to "Sell" at Wall Street Zen
Wall Street Zen lowered shares of Compass Therapeutics from a "hold" rating to a "sell" rating in a research report on Sunday...
MarketBeat·22d ago
News Placeholder
Compass Therapeutics (NASDAQ:CMPX) Sets New 1-Year High - Here's What Happened
Compass Therapeutics (NASDAQ:CMPX) Hits New 1-Year High - What's Next...
MarketBeat·26d ago
News Placeholder
Wall Street Zen Upgrades Compass Therapeutics (NASDAQ:CMPX) to "Hold"
Wall Street Zen raised Compass Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·30d ago
News Placeholder
Are Medical Stocks Lagging ResMed (RMD) This Year?
Here is how ResMed (RMD) and Compass Therapeutics, Inc. (CMPX) have performed compared to their sector so far this year.
Zacks·1mo ago
<
1
2
...
>

Latest CMPX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.